Rani Therapeutics Holdings (RANI) Long-Term Debt Repayments (2024 - 2025)
Rani Therapeutics Holdings (RANI) posted quarterly Long-Term Debt Repayments of $9.5 million for Q4 2025, up 152.59% year-over-year from $3.8 million in Q4 2024, and up 152.59% quarter-over-quarter from $3.8 million in Q3 2025.
Rani Therapeutics Holdings (RANI) Long-Term Debt Repayments (2024 - 2025) Analysis & Trends
Rani Therapeutics Holdings' Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at $9.5 million for Q4 2025.
- In Q4 2025, Long-Term Debt Repayments rose 152.59% year-over-year to $9.5 million; the TTM figure through Mar 2026 stood at $17.0 million (up 93.97% YoY), while the FY2025 annual figure was $20.7 million, up 314.44% from the prior year.
- Long-Term Debt Repayments for Q4 2025 stood at $9.5 million, up from $3.8 million in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $9.5 million in Q4 2025, with the low at $1.2 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 17.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -10.01 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Rani Therapeutics Holdings | 163.98 Mn | 163.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.47 Mn |
| Dec 31, 2025 | 9.47 Mn |
| Sep 30, 2025 | 3.75 Mn |
| Sep 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | 3.75 Mn |
| Mar 31, 2025 | 3.75 Mn |
| Dec 31, 2024 | 3.75 Mn |
| Dec 31, 2024 | 3.75 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.25 Mn |